Home

Bestrafung Meilenstein Krug ecco 2014 mantzaris gerassimos Sanft Beschreiben Schraube

PDF) P621 Real-world effectiveness and safety of vedolizumab and anti-TNF  in biologic-naive Crohn's disease patients: results from the EVOLVE study
PDF) P621 Real-world effectiveness and safety of vedolizumab and anti-TNF in biologic-naive Crohn's disease patients: results from the EVOLVE study

Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic

PDF) Oral azathioprine for steroid refractory severe ulcerative colitis | Gerassimos  Mantzaris - Academia.edu
PDF) Oral azathioprine for steroid refractory severe ulcerative colitis | Gerassimos Mantzaris - Academia.edu

PDF) Prevalence and Characteristics of Extra-intestinal Manifestations in a  Large Cohort of Greek Patients with Inflammatory Bowel Disease
PDF) Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease

ECCO
ECCO

European Crohn´s and Colitis Organisation - ECCO - The Council of National  Representatives
European Crohn´s and Colitis Organisation - ECCO - The Council of National Representatives

Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic

John TRIANTAFILLIDIS | Inflammatory Bowel Disease Unit, IASO General  Hospital, Athens, Greece | Associate Professor, University of Medicine and  Pharmacy, Iasi, Romania | IASO Hospital, Athens, Athens | IASO | IBD unit
John TRIANTAFILLIDIS | Inflammatory Bowel Disease Unit, IASO General Hospital, Athens, Greece | Associate Professor, University of Medicine and Pharmacy, Iasi, Romania | IASO Hospital, Athens, Athens | IASO | IBD unit

European Crohn´s and Colitis Organisation - ECCO - The Council of National  Representatives
European Crohn´s and Colitis Organisation - ECCO - The Council of National Representatives

ECCO in Vienna was the Best Congress Ever!
ECCO in Vienna was the Best Congress Ever!

Orally Administered Platinum Nanomarkers for Urinary Monitoring of  Inflammatory Bowel Disease | ACS Nano
Orally Administered Platinum Nanomarkers for Urinary Monitoring of Inflammatory Bowel Disease | ACS Nano

NewsWINTER
NewsWINTER

Tibor HLAVATY | Senior gastroenterologist | MD, PhD, Assoc. Prof |  Department of internal medicine V. | Research profile
Tibor HLAVATY | Senior gastroenterologist | MD, PhD, Assoc. Prof | Department of internal medicine V. | Research profile

PDF) Budesonide is superior to mesalazine in maintaining disease remission  for patients with steroid-dependent Crohn's disease | Gerassimos Mantzaris  - Academia.edu
PDF) Budesonide is superior to mesalazine in maintaining disease remission for patients with steroid-dependent Crohn's disease | Gerassimos Mantzaris - Academia.edu

Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic

Inflammatory Bowel Diseases
Inflammatory Bowel Diseases

ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel  Disease—An Update
ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease—An Update

Untitled
Untitled

WINTER
WINTER

European Crohn´s and Colitis Organisation - ECCO - The Council of National  Representatives
European Crohn´s and Colitis Organisation - ECCO - The Council of National Representatives

Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic

European Crohn´s and Colitis Organisation - ECCO - The Council of National  Representatives
European Crohn´s and Colitis Organisation - ECCO - The Council of National Representatives

Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in  Biologic-Naïve Inflammatory Bowel Disease Patients: Resul
Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Resul

European Crohn´s and Colitis Organisation - ECCO - Uncategorised
European Crohn´s and Colitis Organisation - ECCO - Uncategorised

Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic
Editorial_Board | Journal of Crohn's and Colitis | Oxford Academic

s of ECCO
s of ECCO

Clinical profiles of moderate and severe Crohn's disease patients and use  of anti-tumor necrosis factor agents: Greek expert consensus guidelines. -  Abstract - Europe PMC
Clinical profiles of moderate and severe Crohn's disease patients and use of anti-tumor necrosis factor agents: Greek expert consensus guidelines. - Abstract - Europe PMC